US Patent Issued to Takeda Pharmaceutical on Dec. 23 for "Treatment of central nervous system disorders by intranasal administration of immunoglobulin G" (Minnesota, Illinois Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,501, issued on Dec. 23, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Treatment of central nervous system disorders by intranasal administration of immunoglobulin G" was invented by William H. Frey II (White Bear Lake, Minn.), Leah Ranae Bresin Hanson (Vadnais Heights, Minn.), Sharon Pokropinski (Schaumburg, Ill.) and Francisco M. Rausa III (Vernon Hills, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, among other aspects, methods and compositions for treating a central nervous system (CNS) disorder by delivering a therapeutically effective amount of a composition of pooled human immunoglobulin G...